Insights on Private Equity

ArentFox Schiff served as legal counsel to American Skating Entertainment Centers, LLC, a leading owner and operator of ice-skating and indoor sports facilities across the United States, including Toyota Sports Performance Center home of the LA KINGS, UCLA Health Training Center home of the LA Lakers, Wake Competition Center home of the Carolina Hurricanes, and the LA Galaxy Soccer Center, in connection with its strategic partnership with Seidler Equity Partners.

ArentFox Schiff represented the National Women’s Soccer League (NWSL) in connection with the Miller family’s acquisition of a majority stake in the Utah Royals FC club. The Miller family brings a longstanding legacy in local professional sports ownership, having previously owned the NBA’s Utah Jazz from 1985 to 2020.

Health Care Counsel Gayland Hethcoat will share insights into the potential future of private equity (PE) in health care in a HealthExecStore webinar on April 16, 2025.

The US Securities and Exchange Commission (SEC) released a press release on January 15 announcing that it had charged Navy Capital Green Management, LLC, an investment adviser, with violations of the Investment Advisers Act of 1940 related to its Anti-Money Laundering (AML) policies and procedures.

On December 30, 2024, the Massachusetts state legislature passed House Bill 4653 (the Act), which significantly enhances regulatory oversight in the Massachusetts health care market. As signed into law by Governor Maura Healy on January 8, the Act will have profound effects for private equity (PE) investors and real estate investment trusts (REITs) engaging with the Massachusetts health care market. Passage of the Act comes on the heels of prominent PE-backed hospital failures in Massachusetts.

David Barbash will present at the Boston Smart Business Dealmakers Conference “Structuring the Financial and Operational Terms for Acquisitional Deals” on March 7, 2024.

The sports industry experienced a year of considerable change in 2023, presenting new opportunities for athletes, team owners, and corporate sponsors.

Mark Zaander will speak on a panel that Tyler Margolis will moderate at the ACIC Spring Investment Forum on April 28, 2023.

On March 27, the US Securities and Exchange Commission (SEC) released a risk alert focusing on the SEC’s conclusions after its routine examination of newly registered investment advisors.

ArentFox Schiff advised Kindeva Drug Delivery in its combination with Meridian Medical Technologies.

On August 10, 2022, the US Securities and Exchange Commission (SEC) and the Commodity Futures Trading Commission (CFTC) issued a joint proposal to amend Form PF,[1] a reporting form for SEC-registered reporting private fund advisers to require enhanced periodic disclosures.

ArentFox Schiff is pleased to announce that the firm and two partners have been shortlisted for the annual LMG Life Sciences Americas Awards.

On June 14, 2022, the US Securities and Exchange Commission (SEC) released an order charging private equity adviser Energy Capital Partners Management, LP (ECP) with Investment Advisers Act violations in connection with a 2018 take-private transaction.

ArentFox Schiff advised Altaris Capital Partners on the approximately $241 million take-private acquisition of Intricon Corporation, an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging.

ArentFox Schiff is representing Clearwater Compliance LLC (Clearwater) in its definitive agreement for the take-private acquisition of CynergisTek, Inc., a leading cybersecurity, privacy, compliance, and IT audit firm.

Centre Partners, a private equity firm specializing in the healthcare and consumer industries, engaged ArentFox Schiff to represent physician-owners and management in the sale of Vision Innovation Partners.

Schiff Hardin today announced the expansion of its Corporate and Transactional Practice Group with the addition of counsel Andrew Banks in New York and associates Darcy Lee and Cody Boender in Chicago.

Schiff has advised BK Medical in entering into an agreement to be sold to GE Healthcare for $1.45 billion.

Schiff advised Altaris Capital Partners, LLC on its acquisition of Padagis LLC, formerly the generic prescription pharmaceuticals business of Perrigo Company plc, for $1.55 billion.

Altaris Capital Partners, LLC has announced that it has entered into an agreement to sell Paramit Corporation to The Tecan Group for $1 billion.

Schiff Hardin represented Altaris Capital Partners, LLC in the sale of Senior Helpers, an owner and franchisor of professional home care services designed to allow elderly individuals to stay in their homes as long as possible.

Schiff Hardin LLP represented Altaris Capital Partners, LLC, a private investment firm focused on the healthcare industry, in its agreement to acquire Perrigo Company plc’s prescription pharmaceuticals business (Rx) for $1.55 billion.

Schiff Hardin LLP represented Altaris Capital Partners, LLC, a private investment firm focused on the healthcare industry, in the majority recapitalization of Minnetronix Medical, Inc., a leading medical technology and operations partner to global medical device companies.

Schiff Hardin LLP represented Altaris Capital Partners LLC, a private investment firm focused on the healthcare industry, in its $650 million acquisition of substantially all of Kindeva Drug Delivery from 3M Company.

Schiff Hardin LLP represented Newell Brands, a leading global consumer goods company, in the sale of its Rexair business to investment funds affiliated with Rhône Capital, a global private equity firm.